Stock Events

Stock Events

Medpace 

€495
206
+€0+0% Friday 16:06

Statistics

Day High
509
Day Low
495
52W High
554.2
52W Low
260.9
Volume
13
Avg. Volume
0
Mkt Cap
13.94B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

9FebExpected
Q1 2025
Q2 2025
Q3 2025
Next
2.55
2.88
3.21
3.53
Expected EPS
3.5324136045
Actual EPS
N/A

Financials

19.19%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
4BRevenue
767.81MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 1MEDP.MI. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
IQVIA
IQV
Mkt Cap36.86B
IQVIA provides similar contract research services, making it a direct competitor in the pharmaceutical and biotech industry.
Charles River Laboratories International
CRL
Mkt Cap8.86B
Charles River Laboratories offers a broad range of preclinical and clinical laboratory services, directly competing with Medpace's research services.
Icon Energy
ICON
Mkt Cap3.59M
ICON plc provides clinical research services across a wide range of therapeutic areas, competing directly with Medpace in the CRO space.
Evolent Health
EVH
Mkt Cap773.53M
Evolent Health offers services that, while more focused on healthcare delivery and payment, indirectly compete with Medpace in the broader healthcare services market.

About

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.
Show more...
CEO
Dr. August James Troendle M.D.
Employees
5000
Country
United States
ISIN
US58506Q1094

Listings

MI
IT
1MEDP.MI
BOATS
BOATS
MEDP.BOATS
MX
MX
MEDP.MX
XNAS
US
MEDP

0 Comments

Share your thoughts

FAQ

What is Medpace stock price today?▼
The current price of 1MEDP.MI is €495 EUR — it has increased by +0% in the past 24 hours. Watch Medpace stock price performance more closely on the chart.
What is Medpace stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Medpace stocks are traded under the ticker 1MEDP.MI.
What is Medpace market cap?▼
Today Medpace has the market capitalization of 13.94B
When is the next Medpace earnings date?▼
Medpace is going to release the next earnings report on February 09, 2026.
What were Medpace earnings last quarter?▼
1MEDP.MI earnings for the last quarter are 3.33 EUR per share, whereas the estimation was 3.04 EUR resulting in a +9.2% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Medpace revenue for the last year?▼
Medpace revenue for the last year amounts to 4B EUR.
What is Medpace net income for the last year?▼
1MEDP.MI net income for the last year is 767.81M EUR.
How many employees does Medpace have?▼
As of February 02, 2026, the company has 5,000 employees.
In which sector is Medpace located?▼
Medpace operates in the Healthcare sector.
When did Medpace complete a stock split?▼
Medpace has not had any recent stock splits.
Where is Medpace headquartered?▼
Medpace is headquartered in Cincinnati, United States.